Pathology

Article	Citations
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation	143
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings	73
The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment	61
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent	48
Clear cell papillary renal cell carcinoma: an update after 15 years	38
Chromophobe renal cell carcinoma: current and controversial issues	34
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays	33
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection	31
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings	30
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour	29
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis	27
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2	26
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays	25
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship	25
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma	25
Staging of renal cell carcinoma: current progress and potential advances	24
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour	22
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia	22
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes	21
Granular necrosis: a distinctive form of cell death in malignant tumours	21
Emergence of Japanese encephalitis in Australia: a diagnostic perspective	21
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer	20
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients	19
HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma	18
Molecular pathology of prostate cancer: a practical approach	18

Malignant mesothelioma in situ: diagnostic and clinical considerations	18
Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge	17
New developments in non-Hodgkin lymphoid malignancies	16
Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens	15
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2	15
Tumour-like lesions of the urinary bladder	15
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes	15
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study	14
Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use	14
Machine learning and augmented human intelligence use in histomorphology for haematolymphoid disorders	14
Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortality	14
Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia	13
Myeloid somatic mutation panel testing in myeloproliferative neoplasms	13
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations	13
EBV positive fibrin/chronic inflammation associated diffuse large B-cell lymphoma: an incidental finding associated with a breast implant	13
Prognostic features of Annexin A2 expression in prostate cancer	13
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context	13
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer	13
Variability in D-dimer reporting revisited	13
Stage T1 bladder cancer: diagnostic criteria and pitfalls	13
Oral anticoagulation therapy: an update on usage, costs and associated risks	12
Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer	12
Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases	12
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection	12
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant	12
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low	12
The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma	12
Benign mimics of prostate cancer	11
An update on genomic aberrations in Spitz naevi and tumours	11
Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas	11
Role of cell-free DNA in haematological malignancies	11
CAR-T cell therapy: practical guide to routine laboratory monitoring	11
Clonal haematopoiesis of emerging significance	11
Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas!	11
Using deep learning for quantification of cellularity and cell lineages in bone marrow biopsies and comparison to normal age-related variation	10
Two cases of ZC3H7B-BCOR high grade endometrial stromal sarcoma with an extension on its morphological features	10
Tumour mutational burden: an overview for pathologists	10
Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies	10
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory	10
Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer	10
An evaluation of existing manual blood film schistocyte quantitation guidelines and a new proposed method	10
Genomic characterisation of diffuse large B-cell lymphoma	10
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics	10
A Mycobacterium species for Crohn's disease?	9
Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology s	9
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients	9
Atypia in breast pathology: what pathologists need to know	9
Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma	9
Genomic analysis of Lactococcus garvieae isolates	9
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures	9

Diagnostic error, uncertainty, and overdiagnosis in melanoma	9
Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status	9
Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding	9
NKX3.1 expression in cervical ‘adenoid basal cell carcinoma’: another gynaecological lesion with prostatic differentiation?	9
GLI activated epithelioid cell tumour: report of a case and proposed new terminology	9
The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes	9
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests	9
Urothelial carcinoma in situ: diagnostic update	9
Hybrid sclerosing epithelioid fibrosarcoma/low grade fibromyxoid sarcoma arising in the small intestine with distinct HEY1-NCOA2 gene fusion	9
Comparison of a commercial real-time PCR panel to routine laboratory methods for the diagnosis of meningitis-encephalitis	8
SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability	8
LncRNA PVT1 promotes the malignant progression of acute myeloid leukaemia via sponging miR-29 family to increase WAVE1 expression	8
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis	8
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing	8
Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients	8
Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas	8
Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene	8
Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma	8
Progression of mesothelioma in situ to invasive disease 4 years and 10 months after initial diagnosis	8
Should the solid variant of odontogenic keratocyst and keratoameloblastoma be classified as the same entity? A clinicopathological analysis of nine cases and a review of the literature	8
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection	8
The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma	8
Prostatic stromal proliferations: a review	8
Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma	8
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020	8
The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders	8
HPV-driven anal neoplasia: review and recent developments	7
Metastatic melanoma and rare melanoma variants: a review	7
Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection?	7
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial	7
Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting	7
Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site	7
A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care	7
Erythrocyte interaction with neutrophil extracellular traps in coronary artery thrombosis following myocardial infarction	7
Programmed death ligand 1 protein expression, histological tumour differentiation and intratumoural heterogeneity in pulmonary adenocarcinoma	7
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis	7
Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy	7
Knowledge at what cost? An audit of the utility of panfungal PCR performed on bronchoalveolar lavage fluid specimens at a tertiary mycology laboratory	7
Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex	7
Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition	6
Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome	6
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma	6
The biology of pancreatic cancer morphology	6
Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study	6
Inflammatory pseudotumour arising secondary to VEXAS syndrome	6
Blood culture quality assurance: what Australasian laboratories are measuring and opportunities for improvement	6
Quantitative Pneumocystis jirovecii real-time PCR to differentiate disease from colonisation	6
Cytological diagnosis of mesothelioma in situ versus invasive mesothelioma	6
NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China	6
Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis	6
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney	6
Comparison of three commercially available ELISA assays for anti-infliximab antibodies	6
Assessment of analytical bias in ferritin assays and impact on functional reference limits	6
Gleason grade 5 prostate cancer: sub-patterns and prognosis	6
Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia	6
Impact of new myeloma agents on the transfusion laboratory	6
Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms	6
Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma	6
SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis	6
Assessment of European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines in an Australian paediatric population	6
Actinomycosis canaliculitis	6
Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system	6
Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia	5
Proficiency testing for SARS-CoV-2 whole genome sequencing	5
Report of a classic primordial odontogenic tumour and an unusual mixed odontogenic tumour with features of primordial odontogenic tumour: diagnostic implications	5
Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours	5
Controversies in appendiceal pathology: mucinous and goblet cell neoplasms	5
Biology and genetics of acquired and congenital melanocytic naevi	5
The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma	5
Beware the inflammatory cell-rich colonic polyp: a rare case of EBV-positive inflammatory pseudotumour-like follicular dendritic cell sarcoma with increased IgG4-positive plasma cells	5
Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples	5
Prognostic and predictive biomarkers in melanoma	5
A NUT carcinoma lacking squamous differentiation and expressing TTF1	5
Publication metrics: what do they mean?	5
Highlights of infectious agents in tissue	5
Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories	5
An overview of artificial intelligence/deep learning	5
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features	5
Candida duobushaemulonii sepsis and Candida auris co-isolation following hospitalisation in Vietnam	5
Gynaecological or gastrointestinal origin? Recognising Müllerian neoplasms with gastrointestinal phenotype and determining the primary site in selected entities	5

Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA	5
Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C	5
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting	5
Gastrointestinal polyposis with associated cutaneous manifestations	4
Gonadoblastoma in individuals with a normal karyotype and no evidence of a disorder of sex development	4
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases	4
An update on genetic aberrations in T-cell neoplasms	4
Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay	4
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1	4
The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature	4
Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis	4
Expression and localisation of methylthioadenosine phosphorylase (MTAP) in oral squamous cell carcinoma and their significance in epithelial-to-mesenchymal transition	4
IgG4-related pseudotumours: a series of 12 cases and a review of the literature	4
Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications	4
Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma	4
Imaging flow cytometry shows monosomy 17 in circulating plasma cells in myeloma	4
Recurrent plexiform angiomyxoid myofibroblastic tumour (PAMT) of the stomach with aggressive behaviour	4
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma	4
Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)	4
Oxford nanopore next generation sequencing in a front-line clinical microbiology laboratory without on-site bioinformaticians	4
Usual interstitial pneumonia: a review of the pathogenesis and discussion of elastin fibres, type II pneumocytes and proposed roles in the pathogenesis	4
Agminated Spitz naevus with an activating HRAS Q61R mutation	4
Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma	4
Assessing the performance of the Cepheid Xpert in identifying and differentiating methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus from blood culture bottl	4
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance	4
Analysis of SARS-CoV-2 real-time PCR test CT values across a population may afford useful information to assist public health efforts and add refinement to epidemiological models	4
Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis	4
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort	4
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax	4
Liver mesenchymal neoplasms: something old, something new	4
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of mult	4
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer	4
Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests	4
Epstein–Barr virus is a promoter of lymphoma cell metastasis	4
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting	4
Melanocytic naevi, melanocytomas and emerging concepts	4
Spinal calcifying pseudoneoplasm of the neuraxis (CAPNON) and CAPNON-like lesions: CAPNON overlapping with calcified synovial cysts	4
The diverse morphology and immunophenotype of ovarian endometrioid carcinomas	4
Cemento-osseous dysplasia is caused by RAS-MAPK activation	4
Blue naevi and the blue tumour spectrum	4
Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study	4
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population	4
Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method	4
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort	4
Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation	4
Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case	4
Contributions of genetics to the evolution of the diagnostic classification of renal cell neoplasia: a personal perspective	3
Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma	3
Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis	3
Intravascular epithelioid haemangioma of deep soft tissue with novel SETD1B-FOSB gene rearrangement	3
Prognostic and predictive biomarkers in non-small cell lung carcinoma	3
Lack of standardisation in interpretation and reporting of autoantibody assays: a survey analysis of Australasian laboratories with focus on line immunoassays	3
Relative effects of direct spread, lymph node metastasis and venous invasion in relation to blood borne distant metastasis present at the time of resection of colorectal cancer	3
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma	3
Molecular testing in melanoma for the surgical pathologist	3
Improved performance of confirmatory assays for detecting dense fine speckled (DFS) 70 antibodies	3
Subungual melanoma with blue naevus-like morphological features: a clinicopathological retrospective analysis of nine cases	3
HMGCR autoantibody testing: two tiers required	3
Laboratory diagnosis of HIV: a contemporary overview in the Australian context	3
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy	3
Idiopathic granulomatous mastitis and cystic neutrophilic granulomatous mastitis: two sides of the same coin or distinct entities?	3
YJ5 as an immunohistochemical marker of osteogenic lineage	3
Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis	3
Prolonged PCR positivity in elderly patients infected with SARS-CoV-2	3
Missing parameters in malignant polyp histology reports: can appropriate decisions be made?	3
Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories	3
Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing	3
Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems	3
HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study	3
Gluten-free diet adherence and implications for the diagnosis of coeliac disease	3
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread	3
Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play	3
Antifungal susceptibility of clinical mould isolates in New Zealand, 2001–2019	3
Malignant gastrointestinal neuroectodermal tumour in soft tissue	3
Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods	3
Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram	3
Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants	3
Incidental intravascular large B-cell lymphoma in a renal cell carcinoma	3
Meningioma sampling: how much is enough for the accurate grading of atypical meningiomas?	3
Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer	3
Cutaneous clear cell sarcoma with an epidermal component mimicking melanoma	3
Efficacy of training a deep learning model for mitotic count in breast carcinoma using opensource software	3
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia	3
Intratubular large cell hyalinising Sertoli-cell neoplasia: a rare entity associated with Peutz–Jeghers syndrome	3
Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases	3
Panfungal PCR on formalin-fixed, paraffin-embedded tissue: to proceed or not proceed?	3
Intracranial mesenchymal tumour with EWSR1 gene rearrangement: the first report of intracranial mesenchymal tumour with FET-CREB fusion from India	3
NTRK fusions in solid tumours: what every pathologist needs to know	3
Precision diagnostics: integration of tissue pathology and genomics in cancer	3
The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14	3
Mesenchymal tumours with melanocytic expression: a potential pitfall in the differential diagnosis of malignant melanoma	3
Whole genome sequencing of Salmonella enterica serovar Saintpaul for elucidating the mechanisms of resistance to third generation cephalosporins	3
Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease	3
Review of full blood count reference interval using a large cohort of first-time plasmapheresis blood donors	3
The choice of anti-LEDGF/DFS70 assay matters: a comparative study of six assays	3